FDA-EMA-TGA Joint Inspection Program To Be Permanent; Other Collaborations Expand
Executive Summary
FDA, the European Medicines Agency and Australian Therapeutic Goods Administration intend to make permanent a pilot program allowing for joint facility inspections in what would be another step toward more U.S. reliance on foreign regulator and third-party data and a reduction in inspection burden.
You may also be interested in...
U.S. FDA To Close Office In Amman, Jordan; Says It Is Still Committed To MENA Region
Opened as part of the globalization initiative, U.S. FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.
FDA To Close Office In Amman, Jordan; Operations Moving To White Oak
Opened as part of the globalization initiative, FDA’s presence in the Middle East and North Africa will shut down in late December in an apparent cost-cutting effort.
FDA Inspection Growth In China Stymied By Visa Issues
The agency is waiting for approval to locate 10 new drug inspectors in China.